CCA
TECH icon

Cadent Capital Advisors’s Bio-Techne TECH Stock Holding History

Cadent Capital Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$209K Buy
+2,955
New +$160K 0.04% 195
2022
Q2 		– Sell
-2,112
Closed -$229K – 144
2022
Q1 		$229K Hold
2,112
– – 0.1% 119
2021
Q4 		$273K Sell
2,112
-76
-3% -$9.32K 0.12% 99
2021
Q3 		$265K Hold
2,188
– – 0.12% 100
2021
Q2 		$246K Hold
2,188
– – 0.1% 124
2021
Q1 		$209K Sell
2,188
-420
-16% -$38.3K 0.09% 126
2020
Q4 		$207K Buy
+2,608
New +$189K 0.1% 113

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Cadent Capital Advisors's TECH Position: Q2 2026 in Review

Cadent Capital Advisors opened a new position in Bio-Techne (TECH) in Q2 2026: 2,955 shares worth $209K. The stake represents 0.04% of the portfolio and ranks #195 among its holdings. This is a return to the name: Cadent Capital Advisors previously reported a position in TECH as recently as Q1 2022.

Cadent Capital Advisors first reported a position in TECH in Q4 2020 and has held it in 7 quarters since. The position peaked at $273K in Q4 2021. 595 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Cadent Capital Advisors held 2,955 shares of Bio-Techne worth $209K as of Q2 2026.
  • Bio-Techne was a new Cadent Capital Advisors position in Q2 2026.
  • Bio-Techne made up 0.04% of Cadent Capital Advisors's portfolio in Q2 2026, its #195 holding.
  • Cadent Capital Advisors first reported a position in Bio-Techne in Q4 2020 and has held it in 7 quarters since.
  • Cadent Capital Advisors's Bio-Techne position peaked at $273K in Q4 2021.
  • 595 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Cadent Capital Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.